{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T21:33:20Z","timestamp":1750109600014},"reference-count":24,"publisher":"Baishideng Publishing Group Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJCC"],"published-print":{"date-parts":[[2022,4,16]]},"DOI":"10.12998\/wjcc.v10.i11.3593","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T09:32:06Z","timestamp":1649323926000},"page":"3593-3600","source":"Crossref","is-referenced-by-count":2,"title":["Successful apatinib treatment for advanced clear cell renal carcinoma as a first-line palliative treatment: A case report"],"prefix":"10.12998","volume":"10","author":[{"given":"Hang-Ping","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu-Liang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.9"},{"key":"B2","unstructured":"Xia L, Song YY, Hao RM. Current status and drug development consideration of treatment for advanced renal cell carcinoma. Chin J Clin Pharmacol 2020; 318: 2571-2577"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118632"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.5995"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S126471"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013105"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S126613"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14724"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013372"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100557"},{"key":"B12","unstructured":"Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. Clin Adv Hematol Oncol 2018; 16: 677-686"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14485"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-01408-3"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/app11156930"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.7398"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyab068"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816714"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816047"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/03008916211049275"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2011.01939.x"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15036"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S119129"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v10\/i11\/3593.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T09:34:36Z","timestamp":1649324076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v10\/i11\/3593.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":24,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.12998\/wjcc.v10.i11.3593","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,16]]}}}